TaleNeprilysin and Neprilysin inhibition in chronic kidney disease
<p><strong>Purpose of review </strong></p> Chronic kidney disease (CKD) is associated with increased risk of progression to end-stage kidney disease and cardiovascular events. There is limited evidence that available treatments have beneficial effects on cardiorenal outcomes...
| Päätekijät: | , |
|---|---|
| Aineistotyyppi: | Journal article |
| Kieli: | English |
| Julkaistu: |
Lippincott, Williams & Wilkins
2021
|